Clinical Trial: Microporous Polysaccharide Hemospheres Epistaxis
Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: Use of Microporous Polysaccharide Hemospheres (MPH) in Management of Acute Epistaxis
Brief Summary: The purpose of this study is to compare a new treatment for nosebleeds to the treatment that has been used for many years.
Detailed Summary: Nosebleeds are a common condition which affect many Americans every day.The standard treatment in this hospital for nosebleeds that do not resolve with squeezing the nose or nasal spray is to place a nasal packing (aka nasal tampon) into the nose. This is an effective treatment in most cases, but patients may find it to be uncomfortable. The investigators will be comparing the standard nasal packing with a new type of powder which may also stop nosebleeds.
Sponsor: Emory University
Current Primary Outcome: Number of subjects with resolution of bleed [ Time Frame: 15 minutes (average time to resolve bleeding) ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Time until resolution of bleeding [ Time Frame: 15 minutes (average time to resolve bleeding) ]
Original Secondary Outcome: Same as current
Information By: Emory University
Dates:
Date Received: June 5, 2015
Date Started: January 1, 2015
Date Completion:
Last Updated: January 25, 2017
Last Verified: January 2017